LINGYI CHEN M.D. NPI 1922330844

NPI Information

  • NPI: 1922330844
  • Provider Name: LINGYI CHEN, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1455 HIGDON FERRY RD
    SUITE B
    HOT SPRINGS, AR
    ZIP 71913
  • Phone: (501) 623-2731

Map and Directions

Get Directions

NPI Details

Lingyi Chen, M.D. is a hematology and oncology internal medicine in Hot Springs, AR with 23 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Lingyi Chen, M.D. NPI is 1922330844. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF ARKANSAS COLLEGE OF MEDICINE
Graduation Year:2002

The provider's business location address is:

1455 HIGDON FERRY RD
SUITE B
HOT SPRINGS, AR
ZIP 71913-419
Phone: (501) 623-2731

The NPI 1922330844 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram (HCPCS:J1442)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Unclassified drugs (HCPCS:J3490)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Urinalysis, manual test (HCPCS:81002)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99426)
  • Iron level (HCPCS:83540)
  • Transferrin (iron binding protein) level (HCPCS:84466)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)

The enumeration date for this NPI number is 2/2/2010 and was last updated on 1/27/2017.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyE-10069ARKANSASYes
2207RH0003XInternal MedicineHematology & Oncology47631TENNESSEENo
3207RH0003XInternal MedicineHematology & OncologyMD430216PENNSYLVANIANo

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1103I835932OTHERTENNESSEEMEDCIARE PTAN

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.